SPR Therapeutics
medtech · neuromodulation · pain management
Medtronic completes $650M acquisition of SPR Therapeutics
July 16, 2026
It's the second nine-figure peripheral-nerve-stimulation buyout this year, as device makers race to own non-opioid pain care.
Lead Investors
Medtronic
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.